A Qualitative Comparison of Symptoms and Impact of Varying Stages of Basal Cell Carcinoma

Autor: Arron, Sarah, Steenrod, AW, Smyth, EN, Bush, EN, Chang, ALS, Arron, ST, Helfrich, YR, Von, DD, Brail, LH, Coyne, KS

Publikováno v: Arron, Sarah; Steenrod, AW; Smyth, EN; Bush, EN; Chang, ALS; Arron, ST; et al.(2015). A Qualitative Comparison of Symptoms and Impact of Varying Stages of Basal Cell Carcinoma. UC San Francisco: Retrieved from: http://www.escholarship.org/uc/item/4zc46400

© 2015, The Author(s).Introduction: Basal cell carcinoma (BCC) is the most common form of skin cancer; however, few data are available relating to patients’ perspectives and experiences of this disease. This study explored the spectrum of BCC symp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::058a7d934f6116dfeffd780ed6fac4d1
http://www.escholarship.org/uc/item/4zc46400

Clinicogenomic factors and treatment patterns among patients with advanced non-small cell lung cancer with or without brain metastases in the United States.

Autor: Smyth EN; Eli Lilly and Company, Value Evidence Outcomes - Research, Indianapolis, IN 46225, USA., John J; Eli Lilly and Company, Value Evidence Outcomes - Research, Indianapolis, IN 46225, USA., Tiu RV; Eli Lilly and Company, Value Evidence Outcomes - Research, Indianapolis, IN 46225, USA., Willard MD; Eli Lilly and Company, Lilly Global Clinical Development, Indianapolis, IN 46225, USA., Beyrer JK; Eli Lilly and Company, Value Evidence Outcomes - Research, Indianapolis, IN 46225, USA., Bowman L; Eli Lilly and Company, Value Evidence Outcomes - Research, Indianapolis, IN 46225, USA., Sheffield KM; Eli Lilly and Company, Value Evidence Outcomes - Research, Indianapolis, IN 46225, USA., Han Y; Eli Lilly and Company, Statistics RWE, Indianapolis, IN 46225, USA., Brastianos PK; Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital, Boston, MA 02114, USA.

Publikováno v: The oncologist [Oncologist] 2023 Nov 02; Vol. 28 (11), pp. e1075-e1091.

Characteristics and Outcomes in Cases of US Male Patients with Metastatic Breast Cancer Receiving Abemaciclib in Routine Clinical Practice.

Autor: Ring A; The Royal Marsden Hospital NHS Foundation Trust, Surrey, SM2 5PT, UK. Alistair.Ring@rmh.nhs.uk., Karuturi M; MD Anderson Cancer Center, Houston, TX, USA., Smyth EN; Eli Lilly and Company, Indianapolis, IN, USA., Lokhandwala T; Xcenda LLC, Carrollton, TX, USA., Sheffield KM; Eli Lilly and Company, Indianapolis, IN, USA., Willey J; Xcenda LLC, Carrollton, TX, USA., Lunacsek O; Xcenda LLC, Carrollton, TX, USA., Sapunar F; Eli Lilly and Company, Lilly House, Basingstoke, Hampshire, UK., Cui ZL; Eli Lilly and Company, Indianapolis, IN, USA., Coutinho A; Xcenda LLC, Carrollton, TX, USA., Rybowski S; Eli Lilly and Company, Indianapolis, IN, USA.

Publikováno v: Advances in therapy [Adv Ther] 2023 May; Vol. 40 (5), pp. 2515-2523. Date of Electronic Publication: 2023 Mar 30.

Development of a Prognostic Factor Index Among Women With HR ⁺ /HER2 ^- Metastatic Breast Cancer in a Community Oncology Setting.

Autor: Vidal GA; West Cancer Center and Research Institute, Germantown, TN., Carter GC; Eli Lilly and Company, Indianapolis, IN., Gilligan AM; ConcertAI (formerly Vector Oncology), Memphis, TN. Electronic address: adrienne.texas@gmail.com., Saverno K; Eli Lilly and Company, Indianapolis, IN., Zhu YE; Eli Lilly and Company, Indianapolis, IN., Price GL; Eli Lilly and Company, Indianapolis, IN., DeLuca A; Eli Lilly and Company, Indianapolis, IN., Smyth EN; Eli Lilly and Company, Indianapolis, IN., Rybowski S; Eli Lilly and Company, Indianapolis, IN., Huang YJ; Eli Lilly and Company, Indianapolis, IN., Schwartzberg LS; West Cancer Center and Research Institute, Germantown, TN.

Publikováno v: Clinical breast cancer [Clin Breast Cancer] 2021 Aug; Vol. 21 (4), pp. 317-328.e7. Date of Electronic Publication: 2021 Jan 01.

Treatment patterns, survival and economic outcomes in Medicare-enrolled, older patients with HR+/HER2- metastatic breast cancer.

Autor: Goyal RK; RTI Health Solutions, Research Triangle Park , Durham , NC , USA., Carter GC; Eli Lilly and Company , Indianapolis , IN , USA., Nagar SP; RTI Health Solutions, Research Triangle Park , Durham , NC , USA., Smyth EN; Eli Lilly and Company , Indianapolis , IN , USA., Price GL; Eli Lilly and Company , Indianapolis , IN , USA., Huang YJ; Eli Lilly and Company , Indianapolis , IN , USA., Li L; Eli Lilly and Company , Indianapolis , IN , USA., Davis KL; RTI Health Solutions, Research Triangle Park , Durham , NC , USA., Kaye JA; RTI Health Solutions , Waltham , MA , USA.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2019 Oct; Vol. 35 (10), pp. 1699-1710. Date of Electronic Publication: 2019 Jun 12.